Status | Study |
Completed |
Study Name: Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease Condition: Anemia, Sickle Cell Hemoglobin SC Disease Date: 2008-01-14 Interventions: Behavioral: PAINReportIt A pai |
Terminated |
Study Name: Far Infrared Radiation for Sickle Cell Pain Management Condition: Anemia, Sickle Cell Date: 2008-01-11 Interventions: Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Far infrared radiation for 30 to 40 |
Terminated |
Study Name: Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP Condition: Sickle Cell Disease Hemoglobin SC Date: 2007-12-19 Interventions: Drug: Busulfan Starting Day -9 |
Terminated |
Study Name: Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease Condition: Hemoglobin SC Disease Date: 2007-09-20 Interventions: Drug: Hydroxyurea HU capsules |
Completed |
Study Name: Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies Condition: Hemoglobinopathies Sickle Cell Disease Thalassemia Date: 2005-09-08 Interventions: Drug: Busulfex Given once dail |
Terminated |
Study Name: Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate Condition: HEMOGLOBIN SC DISEASE Date: 2002-06-26 Interventions: Drug: Mg Pidolate Mag 2 will b |
Terminated |
Study Name: Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies Condition: Sickle Cell Anemia Hemoglobinopathy Thalassemia Date: 2002-06-26 Interventions: Drug: Campath -1H Drug: Dilantin |
Terminated |
Study Name: Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia Condition: Hemoglobinopathies Anemia, Sickle Cell Date: 2002-04-30 Interventions: Drug: Busulfan 0.8 mg/kg/d adm |
Completed |
Study Name: A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders Condition: Hemoglobin SC Disease Sickle Cell Anemia Date: 2000-06-03 Interventions: Drug: Recombinant-methionyl human stem cell factor |